Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 4:37 pm Sale | 13G | Mirum Pharmaceuticals Inc. MIRM | BIOTECHNOLOGY VALUE FUND L P | 3,075,907 6.400% | -1,294,117 (-29.61%) | View |
| 2024-11-14 12:55 pm Sale | 13G | Mirum Pharmaceuticals Inc. MIRM | JANUS HENDERSON GROUP PLC JHG | 4,480,284 9.400% | -508,463 (-10.19%) | View |
| 2024-11-14 12:25 pm Purchase | 13G | Mirum Pharmaceuticals Inc. MIRM | EVENTIDE ASSET MANAGEMENT LLC | 3,445,363 7.220% | 751,782 (+27.91%) | View |
| 2024-11-12 11:44 am Purchase | 13G | Mirum Pharmaceuticals Inc. MIRM | BlackRock Inc. | 3,406,072 7.100% | 37,915 (+1.13%) | View |
| 2024-10-22 6:06 pm Purchase | 13G | Mirum Pharmaceuticals Inc. MIRM | BlackRock Inc. | 3,368,157 7.100% | 3,368,157 (New Position) | View |
| 2024-07-10 1:12 pm Purchase | 13G | Mirum Pharmaceuticals Inc. MIRM | JANUS HENDERSON GROUP PLC JHG | 4,988,747 10.600% | 4,988,747 (New Position) | View |
| 2024-02-14 12:49 pm Purchase | 13G | Mirum Pharmaceuticals Inc. MIRM | EVENTIDE ASSET MANAGEMENT LLC | 2,693,581 5.780% | 636,581 (+30.95%) | View |
| 2024-02-13 5:09 pm Purchase | 13G | Mirum Pharmaceuticals Inc. MIRM | VANGUARD GROUP INC | 2,476,244 5.310% | 2,476,244 (New Position) | View |
| 2024-01-31 2:08 pm Purchase | 13G | Mirum Pharmaceuticals Inc. MIRM | BlackRock Inc. BLK | 2,532,642 5.400% | 854,735 (+50.94%) | View |
| 2023-12-29 4:01 pm Sale | 13D | Mirum Pharmaceuticals Inc. MIRM | New Enterprise Associates 16 L.P. | 0 0.000% | -2,186,243 (Position Closed) | View |
| 2023-09-18 4:35 pm Purchase | 13G | Mirum Pharmaceuticals Inc. MIRM | BIOTECHNOLOGY VALUE FUND L P | 4,370,024 9.400% | 4,370,024 (New Position) | View |
| 2023-09-05 3:11 pm Purchase | 13D | Mirum Pharmaceuticals Inc. MIRM | Frazier Life Sciences IX L.P. | 6,226,392 13.400% | 1,815,285 (+41.15%) | View |
| 2023-06-23 2:32 pm Sale | 13D | Mirum Pharmaceuticals Inc. MIRM | New Enterprise Associates 16 L.P. | 2,186,243 5.800% | -2,000,000 (-47.78%) | View |
| 2023-05-03 4:58 pm Sale | 13G | Mirum Pharmaceuticals Inc. MIRM | Flynn James E | 0 0.000% | -2,032,335 (Position Closed) | View |
| 2023-04-14 12:45 pm Purchase | 13D | Mirum Pharmaceuticals Inc. MIRM | Frazier Life Sciences IX L.P. | 4,411,107 11.600% | 549,326 (+14.22%) | View |
| 2023-03-08 2:15 pm Sale | 13G | Mirum Pharmaceuticals Inc. MIRM | BlackRock Inc. BLK | 1,677,907 4.600% | -458,770 (-21.47%) | View |
| 2023-02-14 3:00 pm Purchase | 13G | Mirum Pharmaceuticals Inc. MIRM | Rock Springs Capital Management LP | 1,795,733 4.870% | 256,919 (+16.70%) | View |
| 2023-02-14 1:34 pm Purchase | 13G | Mirum Pharmaceuticals Inc. MIRM | EVENTIDE ASSET MANAGEMENT LLC | 2,057,000 5.600% | 2,057,000 (New Position) | View |
| 2023-02-10 09:34 am Unchanged | 13G | Mirum Pharmaceuticals Inc. MIRM | Flynn James E | 2,032,335 5.510% | 0 (Unchanged) | View |
| 2023-02-03 4:27 pm Purchase | 13G | Mirum Pharmaceuticals Inc. MIRM | BlackRock Inc. BLK | 2,136,677 5.800% | 2,136,677 (New Position) | View |